Radiosurgery in Treating Patients With Kidney Tumors

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 20, 2007

Primary Completion Date

March 12, 2017

Study Completion Date

September 12, 2019

Conditions
Kidney Cancer
Interventions
RADIATION

stereotactic radiosurgery

"Series I: Radiation will be delivered in 4 fractions.~Series II: Radiation will be delivered in 3 fractions."

PROCEDURE

Renal Biopsy

At 6 months,an optional percutaneous renal biopsy will be obtained of the targeted tumor, under ultrasound (US) or CT guidance.

PROCEDURE

Serum Blood Markers

ELISA blood testing just prior to and immediately following each daily radiation therapy session. Approximately 5cc of blood will be collected within 2 hours prior to and following completion of fractionated radiation therapy to assess the levels of MIF (both MIF-1 and MIF-2) and VEGF.

Trial Locations (3)

44122

UH-Chagrin Highlands, Orange

44145

UH-Westlake, Westlake

44106-5065

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00458484 - Radiosurgery in Treating Patients With Kidney Tumors | Biotech Hunter | Biotech Hunter